domingo, 15 de septiembre de 2019

Reviews from journal of experimental & clinical cancer research

Reviews from journal of experimental & clinical cancer research



Reviews from Journal of Experimental & Clinical Cancer Research

Below is a summary of all reviews published in JECCR. 
Page 1 of 4
  1. Content Type:Review

    Hepatocellular carcinoma (HCC) ranks the most common primary liver malignancy and the third leading cause of tumor-related mortality worldwide. Unfortunately, despite advances in HCC treatment, less than 40% o...
    Authors:Yaojie Fu, Shanshan Liu, Shan Zeng and Hong Shen
    Citation:Journal of Experimental & Clinical Cancer Research 2019 38:396
    Published on: 
  2. Content Type:Review

    Survivin (also named BIRC5) is a well-known cancer therapeutic target. Since its discovery more than two decades ago, the use of survivin as a target for cancer therapeutics has remained a central goal of surv...
    Authors:Fengzhi Li, Ieman Aljahdali and Xiang Ling
    Citation:Journal of Experimental & Clinical Cancer Research 2019 38:368
    Published on: 
  3. Content Type:Review

    Tumor heterogeneity results in differential response to therapy due to the existence of plastic tumor cells, called cancer stem cells (CSCs), which exhibit the property of resistance to therapy, invasion and m...
    Authors:Pavana Thomas, Annapurna Pranatharthi, Cecil Ross and Sweta Srivastava
    Citation:Journal of Experimental & Clinical Cancer Research 2019 38:328
    Published on: 
  4. Content Type:Review

    Malignant tumors are often multifactorial. Epidemiological studies have shown that hyperglycemia raises the prevalence and mortality of certain malignancies, like breast, liver, bladder, pancreatic, colorectal...
    Authors:Wenjie Li, Xuehui Zhang, Hui Sang, Ying Zhou, Chunyu Shang, Yongqing Wang and Hong Zhu
    Citation:Journal of Experimental & Clinical Cancer Research 2019 38:327
    Published on: 
  5. Content Type:Review

    Numerous studies have presented that curcumin could have a positive effect in the prevention of cancer and then in tumor therapy. Several hypotheses have highlighted that curcumin could decreases tumor growth ...
    Authors:Alexandre Vallée, Yves Lecarpentier and Jean-Noël Vallée
    Citation:Journal of Experimental & Clinical Cancer Research 2019 38:323
    Published on: 
  6. Content Type:Review

    Drug resistance represents the major reason of pharmacological treatment failure. It is supported by a broad spectrum of mechanisms, whose molecular bases have been frequently correlated to aberrant protein ph...
    Authors:Christian Borgo and Maria Ruzzene
    Citation:Journal of Experimental & Clinical Cancer Research 2019 38:287
    Published on: 
  7. Content Type:Review

    Gliomas represent the most common type of malignant brain tumor, among which, glioblastoma remains a clinical challenge with limited treatment options and dismal prognosis. It has been shown that the dysregula...
    Authors:Fangling Cheng and Dongsheng Guo
    Citation:Journal of Experimental & Clinical Cancer Research 2019 38:270
    Published on: 
  8. Content Type:Review

    Immunotherapy has become an established pillar of cancer treatment improving the prognosis of many patients with a broad variety of hematological and solid malignancies. The two main drivers behind this succes...
    Authors:Stephan Kruger, Matthias Ilmer, Sebastian Kobold, Bruno L. Cadilha, Stefan Endres, Steffen Ormanns, Gesa Schuebbe, Bernhard W. Renz, Jan G. D’Haese, Hans Schloesser, Volker Heinemann, Marion Subklewe, Stefan Boeck, Jens Werner and Michael von Bergwelt-Baildon
    Citation:Journal of Experimental & Clinical Cancer Research 2019 38:268
    Published on: 
  9. Content Type:Review

    Autophagy is a catabolic process whose activation may help cancer cells to adapt to cellular stress although, in some instances, it can induce cell death. Autophagy stimulation or inhibition has been considere...
    Authors:Mara Cirone, Maria Saveria Gilardini Montani, Marisa Granato, Alessia Garufi, Alberto Faggioni and Gabriella D’Orazi
    Citation:Journal of Experimental & Clinical Cancer Research 2019 38:262
    Published on: 
  10. Content Type:Review

    Targeting checkpoints of immune cell activation has been demonstrated to be the most effective approach for activation of anti-tumor immune responses. Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and p...
    Authors:Anand Rotte
    Citation:Journal of Experimental & Clinical Cancer Research 2019 38:255
    Published on: 
  12. Content Type:Review

    Because of the complexity of the blood-brain barrier (BBB), brain tumors, especially the most common and aggressive primary malignant tumor type arising from the central nervous system (CNS), glioblastoma, rem...
    Authors:George E. D. Petrescu, Alexandru A. Sabo, Ligia I. Torsin, George A. Calin and Mihnea P. Dragomir
    Citation:Journal of Experimental & Clinical Cancer Research 2019 38:231
    Published on: 
  13. Content Type:Review

    Stromal stimuli mediated by growth factor receptors, leading to ligand-independent activation of steroid hormone receptors, have long been implicated in development of breast cancer resistance to endocrine the...
    Authors:Dominika Piasecka, Marcin Braun, Kamila Kitowska, Kamil Mieczkowski, Radzislaw Kordek, Rafal Sadej and Hanna Romanska
    Citation:Journal of Experimental & Clinical Cancer Research 2019 38:230
    Published on: 
  14. Content Type:Review

    Reprogramming of cancer metabolism is a newly recognized hallmark of malignancy. The aberrant glucose metabolism is associated with dramatically increased bioenergetics, biosynthetic, and redox demands, which ...
    Authors:Jinguan Lin, Longzheng Xia, Jiaxin Liang, Yaqian Han, Heran Wang, Linda Oyang, Shiming Tan, Yutong Tian, Shan Rao, Xiaoyan Chen, Yanyan Tang, Min Su, Xia Luo, Ying Wang, Hui Wang, Yujuan Zhou…
    Citation:Journal of Experimental & Clinical Cancer Research 2019 38:218
    Published on: 
  15. Content Type:Review

    Growing preclinical evidence shows that short-term fasting (STF) protects from toxicity while enhancing the efficacy of a variety of chemotherapeutic agents in the treatment of various tumour types. STF reinfo...
    Authors:Stefanie de Groot, Hanno Pijl, Jacobus J. M. van der Hoeven and Judith R. Kroep
    Citation:Journal of Experimental & Clinical Cancer Research 2019 38:209
    Published on: 
  16. Content Type:Review

    Hepatocellular carcinoma (HCC) is one of the most notable lethal malignancies worldwide. However, the molecular mechanisms involved in the initiation and progression of this disease remain poorly understood. O...
    Authors:Haoming Mai, Bin Zhou, Li Liu, Fu Yang, Carly Conran, Yuan Ji, Jinlin Hou and Deke Jiang
    Citation:Journal of Experimental & Clinical Cancer Research 2019 38:198
    Published on: 
    The Correction to this article has been published in Journal of Experimental & Clinical Cancer Research 2019 38:352
  17. Content Type:Review

    Triple negative breast cancer (TNBC), which is typically lack of expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), represents the most aggre...
    Authors:Jiang-Jiang Qin, Li Yan, Jia Zhang and Wei-Dong Zhang
    Citation:Journal of Experimental & Clinical Cancer Research 2019 38:195
    Published on: 
  18. Content Type:Review

    Cancer-associated fibroblasts (CAFs) plays an essential role in cancer cell growth, metabolism and immunoreaction. Autophagy is an intracellular self-degradative process that balances cell energy source and re...
    Authors:Yuanliang Yan, Xi Chen, Xiang Wang, Zijin Zhao, Wenfeng Hu, Shuangshuang Zeng, Jie Wei, Xue Yang, Long Qian, Shuyi Zhou, Lunquan Sun, Zhicheng Gong and Zhijie Xu
    Citation:Journal of Experimental & Clinical Cancer Research 2019 38:171
    Published on: 
  19. Content Type:Review

    Pancreatic cancer is one of the most lethal type of cancers, with an overall five-year survival rate of less than 5%. It is usually diagnosed at an advanced stage with limited therapeutic options. To date, no ...
    Authors:Chin-King Looi, Felicia Fei-Lei Chung, Chee-Onn Leong, Shew-Fung Wong, Rozita Rosli and Chun-Wai Mai
    Citation:Journal of Experimental & Clinical Cancer Research 2019 38:162
    Published on: 
  20. Content Type:Review

    Cancer is currently the second leading cause of death globally and is expected to be responsible for approximately 9.6 million deaths in 2018. With an unprecedented understanding of the molecular pathways that...
    Authors:N. A. Seebacher, A. E. Stacy, G. M. Porter and A. M. Merlot
    Citation:Journal of Experimental & Clinical Cancer Research 2019 38:156
    Published on: 
  21. Content Type:Review

    The recent developments in immuno-oncology have opened an unprecedented avenue for the emergence of vaccine strategies. Therapeutic DNA cancer vaccines are now considered a very promising strategy to activate ...
    Authors:Alessandra Lopes, Gaëlle Vandermeulen and Véronique Préat
    Citation:Journal of Experimental & Clinical Cancer Research 2019 38:146
    Published on: 
  22. Content Type:Review

    Immune checkpoint inhibitor therapy has changed clinical practice for patients with different cancers, since these agents have demonstrated a significant improvement of overall survival and are effective in ma...
    Authors:Francesca Di Modugno, Cristina Colosi, Paola Trono, Giuseppe Antonacci, Giancarlo Ruocco and Paola Nisticò
    Citation:Journal of Experimental & Clinical Cancer Research 2019 38:117
    Published on: 
  23. Content Type:Review

    The p38 mitogen-activated protein kinase (p38MAPK) pathway has been implicated in a variety of pathological conditions including inflammation and metastasis. Post-transcriptional regulation of genes harboring ...
    Authors:Sourabh Soni, Prince Anand and Yogendra S. Padwad
    Citation:Journal of Experimental & Clinical Cancer Research 2019 38:121
    Published on: 
  24. Content Type:Review

    The extracellular matrix (ECM) plays an important role in cancer progression. It can be divided into the basement membrane (BM) that supports epithelial/endothelial cell behavior and the interstitial matrix (I...
    Authors:Neel I. Nissen, Morten Karsdal and Nicholas Willumsen
    Citation:Journal of Experimental & Clinical Cancer Research 2019 38:115
    Published on: 
  25. Content Type:Review

    Novel therapeutic strategies are urgently needed for the treatment of metastatic Urothelial Bladder Cancer. DNA damaging repair (DDR) targeting has been introduced in cinical trials for bladder cancer patients...
    Authors:Daniela Criscuolo, Francesco Morra, Riccardo Giannella, Roberta Visconti, Aniello Cerrato and Angela Celetti
    Citation:Journal of Experimental & Clinical Cancer Research 2019 38:91
    Published on: 
  26. Content Type:Review

    PD-1/PD-L1 checkpoint blockades have achieved significant progress in several kinds of tumours. Pembrolizumab, which targets PD-1, has been approved as a first-line treatment for advanced non-small cell lung c...
    Authors:Xin Wang, Gaochao Guo, Hui Guan, Yang Yu, Jie Lu and Jinming Yu
    Citation:Journal of Experimental & Clinical Cancer Research 2019 38:87
    Published on: 
  28. Content Type:Review

    Telomeres, the nucleoprotein structures that cap the ends of eukaryotic chromosomes, play important and multiple roles in tumorigenesis. Functional telomeres need the establishment of a protective chromatin st...
    Authors:Stefano Cacchione, Annamaria Biroccio and Angela Rizzo
    Citation:Journal of Experimental & Clinical Cancer Research 2019 38:21
    Published on: 
  29. Content Type:Review

    RANKL/RANK/OPG system consists of three essential signaling molecules: i) the receptor activator of nuclear factor (NF)-kB-ligand (RANKL), ii) the receptor activator of NF-kB (RANK), and iii) the soluble decoy...
    Authors:Marco Infante, Alessandra Fabi, Francesco Cognetti, Stefania Gorini, Massimiliano Caprio and Andrea Fabbri
    Citation:Journal of Experimental & Clinical Cancer Research 2019 38:12
    Published on: 
  30. Content Type:Review

    Pancreatic cancer (PC) is among foremost causes of cancer related deaths worldwide due to generic symptoms, lack of effective screening strategies and resistance to chemo- and radiotherapies. The risk factors ...
    Authors:Ramesh Pothuraju, Satyanarayana Rachagani, Wade M. Junker, Sanjib Chaudhary, Viswanathan Saraswathi, Sukhwinder Kaur and Surinder K. Batra
    Citation:Journal of Experimental & Clinical Cancer Research 2018 37:319
    Published on: 
  31. Content Type:Review

    Resistance to regulated cell death is one of the hallmarks of human cancers; it maintains cell survival and significantly limits the effectiveness of conventional drug therapy. Leukemia represents a class of h...
    Authors:Xianbo Huang, Feng Xiao, Yuan Li, Wenbin Qian, Wei Ding and Xiujin Ye
    Citation:Journal of Experimental & Clinical Cancer Research 2018 37:310
    Published on: 
  33. Content Type:Review

    Most chemotherapeutics elevate intracellular levels of reactive oxygen species (ROS), and many can alter redox-homeostasis of cancer cells. It is widely accepted that the anticancer effect of these chemotherap...
    Authors:Haotian Yang, Rehan M Villani, Haolu Wang, Matthew J Simpson, Michael S Roberts, Min Tang and Xiaowen Liang
    Citation:Journal of Experimental & Clinical Cancer Research 2018 37:266
    Published on: 
  34. Content Type:Review

    The mechanism by which c-Myc exerts its oncogenic functions is not completely clear and different hypotheses are still under investigation. The knowledge of the capacity of c-Myc to bind exclusively E-box sequ...
    Authors:Matteo Caforio, Cristina Sorino, Stefano Iacovelli, Maurizio Fanciulli, Franco Locatelli and Valentina Folgiero
    Citation:Journal of Experimental & Clinical Cancer Research 2018 37:239
    Published on: 
  35. Content Type:Review

    Non-small cell lung cancer (NSCLC) accounts for approximately 85% of lung cancer cases, and it is one of the leading causes of cancer death in both men and women worldwide due to diagnosis in the advanced stag...
    Authors:Hongmei Zheng, Yuting Zhan, Sile Liu, Junmi Lu, Jiadi Luo, Juan Feng and Songqing Fan
    Citation:Journal of Experimental & Clinical Cancer Research 2018 37:226
    Published on: 
  36. Content Type:Review

    Phosphatase and tensin homologue (PTEN) triggers a battery of intracellular signaling pathways, especially PI3K/Akt, playing important roles in the pathogenesis of multiple diseases, such as cancer, neurodevel...
    Authors:Wang Li, Ting Zhang, Lianying Guo and Lin Huang
    Citation:Journal of Experimental & Clinical Cancer Research 2018 37:223
    Published on: 
  37. Content Type:Review

    Hepatocellular carcinoma (HCC) is a highly malignant disease with a poor prognosis and high mortality due to a low early diagnosis rate, resistance to systemic treatments and progression to late-stage liver di...
    Authors:Jie Li, Xu Han, Xiaona Yu, Zongzhen Xu, Guangsheng Yang, Bingqi Liu and Peng Xiu
    Citation:Journal of Experimental & Clinical Cancer Research 2018 37:213
    Published on: 
  38. Content Type:Review

    Circular RNAs (circRNAs) are a type of noncoding RNAs with a closed loop structure. With the development of high-throughput sequencing, massive circRNAs have been discovered in tumorous tissues. Emerging evide...
    Authors:Xuehui Wang and Lin Fang
    Citation:Journal of Experimental & Clinical Cancer Research 2018 37:206
    Published on: 
  39. Content Type:Review

    Epithelial-to-mesenchymal transition (EMT) is a complex process involving multiple genes, steps and stages. It refers to the disruption of tight intercellular junctions among epithelial cells under specific co...
    Authors:Long Yan, Feng Xu and Chao-liu Dai
    Citation:Journal of Experimental & Clinical Cancer Research 2018 37:203
    Published on: 
  40. Content Type:Review

    The pathophysiological roles and the therapeutic potentials of Myc family are reviewed in this article. The physiological functions and molecular machineries in stem cells, including embryonic stem (ES) cells ...
    Authors:Go J. Yoshida
    Citation:Journal of Experimental & Clinical Cancer Research 2018 37:173
    Published on: 
    The Correction to this article has been published in Journal of Experimental & Clinical Cancer Research 2018 37:285
  41. Content Type:Review

    Biomarkers are an integral part of cancer management due to their use in risk assessment, screening, differential diagnosis, prognosis, prediction of response to treatment, and monitoring progress of disease. ...
    Authors:Michelle H. Townsend, Gajendra Shrestha, Richard A. Robison and Kim L. O’Neill
    Citation:Journal of Experimental & Clinical Cancer Research 2018 37:163
    Published on: 
  42. Content Type:Correction

    In the publication of this article [1], there is an error in the Figure caption of Figs. 2, 3 and 4. This has now been included in this correction. The authors declare that these corrections do not change the ...
    Authors:Mei Yi, Junjun Li, Shengnan Chen, Jing Cai, Yuanyuan Ban, Qian Peng, Ying Zhou, Zhaoyang Zeng, Shuping Peng, Xiaoling Li, Wei Xiong, Guiyuan Li and Bo Xiang
    Citation:Journal of Experimental & Clinical Cancer Research 2018 37:155
    Published on: 
    The original article was published in Journal of Experimental & Clinical Cancer Research 2018 37:118
  43. Content Type:Review

    The natural history of mantle cell lymphoma (MCL) is a continuous process with the vicious cycle of remission and recurrence. Because MCL cells are most vulnerable before their exposure to therapeutic agents, ...
    Authors:Haige Ye, Aakash Desai, Shengjian Huang, Dayoung Jung, Richard Champlin, Dongfeng Zeng, Fangfang Yan, Krystle Nomie, Jorge Romaguera, Makhdum Ahmed and Michael L. Wang
    Citation:Journal of Experimental & Clinical Cancer Research 2018 37:150
    Published on: 
  44. Content Type:Review

    The immune system is composed of immune as well as non-immune cells. As this system is a well-established component of human papillomavirus- (HPV)-related carcinogenesis, high risk human papillomavirus (hrHPV)...
    Authors:Marconi Rego Barros Jr, Cristiane Moutinho Lagos de Melo, Maria Luiza Carneiro Moura Gonçalves Rego Barros, Rita de Cássia Pereira de Lima, Antonio Carlos de Freitas and Aldo Venuti
    Citation:Journal of Experimental & Clinical Cancer Research 2018 37:137
    Published on: 
  45. Content Type:Review

    Oxidative stress is related to ageing and degenerative diseases, including cancer. However, a moderate amount of reactive oxygen species (ROS) is required for the regulation of cellular signalling and gene exp...
    Authors:Rodrigo Prieto-Bermejo, Marta Romo-González, Alejandro Pérez-Fernández, Carla Ijurko and Ángel Hernández-Hernández
    Citation:Journal of Experimental & Clinical Cancer Research 2018 37:125
    Published on: 
  46. Content Type:Review

    Long non-coding RNAs (lncRNAs) refer to functional cellular RNAs molecules longer than 200 nucleotides in length. Unlike microRNAs, which have been widely studied, little is known about the enigmatic role of l...
    Authors:Lei Zhan, Jun Li and Bing Wei
    Citation:Journal of Experimental & Clinical Cancer Research 2018 37:120
    Published on: 
  47. Content Type:Review

    Oncogenes derived from the neurotrophin receptor tropomyosin-related kinase TrkA act as drivers in sub-populations of a wide-range of human cancers. This, combined with a recent report that both adult and chil...
    Authors:Antonietta Rosella Farina, Lucia Cappabianca, Pierdomenico Ruggeri, Luciana Gneo, Cristina Pellegrini, Maria-Concetta Fargnoli and Andrew Reay Mackay
    Citation:Journal of Experimental & Clinical Cancer Research 2018 37:119
    Published on: 
  48. Content Type:Review

    Cancer stem cells (CSCs) or tumor-initiating cells (TICs) represent a small population of cancer cells with self-renewal and tumor-initiating properties. Unlike the bulk of tumor cells, CSCs or TICs are refrac...
    Authors:Mei Yi, Junjun Li, Shengnan Chen, Jing Cai, Yuanyuan Ban, Qian Peng, Ying Zhou, Zhaoyang Zeng, Shuping Peng, Xiaoling Li, Wei Xiong, Guiyuan Li and Bo Xiang
    Citation:Journal of Experimental & Clinical Cancer Research 2018 37:118
    Published on: 
    The Correction to this article has been published in Journal of Experimental & Clinical Cancer Research 2018 37:155
  49. Content Type:Review

    Immune checkpoints include stimulatory and inhibitory checkpoint molecules. In recent years, inhibitory checkpoints, including cytotoxic T lymphocyte–associated antigen 4 (CTLA-4), programmed cell death protei...
    Authors:Feng Xu, Tianqiang Jin, Yuwen Zhu and Chaoliu Dai
    Citation:Journal of Experimental & Clinical Cancer Research 2018 37:110
    Published on: 
  50. Content Type:Review

    Transfer RNAs (tRNAs), traditionally considered to participate in protein translation, were interspersed in the entire genome. Recent studies suggested that dysregulation was observed in not only tRNAs, but al...
    Authors:Shi-qiong Huang, Bao Sun, Zong-ping Xiong, Yan Shu, Hong-hao Zhou, Wei Zhang, Jing Xiong and Qing Li
    Citation:Journal of Experimental & Clinical Cancer Research 2018 37:101
    Published on: 
Publicado por en

No hay comentarios:

Publicar un comentario

Suscribirse a: Enviar comentarios (Atom)